HUE042607T2 - Eljárások asztma exacerbációs gyakoriságának csökkentésére benralizumab alkalmazásával - Google Patents
Eljárások asztma exacerbációs gyakoriságának csökkentésére benralizumab alkalmazásávalInfo
- Publication number
- HUE042607T2 HUE042607T2 HUE14835826A HUE14835826A HUE042607T2 HU E042607 T2 HUE042607 T2 HU E042607T2 HU E14835826 A HUE14835826 A HU E14835826A HU E14835826 A HUE14835826 A HU E14835826A HU E042607 T2 HUE042607 T2 HU E042607T2
- Authority
- HU
- Hungary
- Prior art keywords
- benralizumab
- exacerbation
- asthma
- frequency
- reducing
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title 1
- 229950000321 benralizumab Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dermatology (AREA)
- Bathtubs, Showers, And Their Attachments (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864944P | 2013-08-12 | 2013-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE042607T2 true HUE042607T2 (hu) | 2019-07-29 |
Family
ID=52448837
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE14835826A HUE042607T2 (hu) | 2013-08-12 | 2014-08-07 | Eljárások asztma exacerbációs gyakoriságának csökkentésére benralizumab alkalmazásával |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US9441037B2 (enExample) |
| EP (1) | EP3033101B1 (enExample) |
| JP (4) | JP6746495B2 (enExample) |
| KR (2) | KR20220057637A (enExample) |
| CN (2) | CN105451760A (enExample) |
| AU (2) | AU2014306956B2 (enExample) |
| BR (1) | BR112016002401A8 (enExample) |
| CA (1) | CA2918105C (enExample) |
| CY (1) | CY1122132T1 (enExample) |
| DK (1) | DK3033101T3 (enExample) |
| ES (1) | ES2716906T3 (enExample) |
| HK (1) | HK1221644A1 (enExample) |
| HR (1) | HRP20190405T1 (enExample) |
| HU (1) | HUE042607T2 (enExample) |
| LT (1) | LT3033101T (enExample) |
| ME (1) | ME03348B (enExample) |
| MX (1) | MX368508B (enExample) |
| PL (1) | PL3033101T3 (enExample) |
| PT (1) | PT3033101T (enExample) |
| RS (1) | RS58404B1 (enExample) |
| RU (1) | RU2676333C2 (enExample) |
| SG (2) | SG10202005560UA (enExample) |
| SI (1) | SI3033101T1 (enExample) |
| SM (1) | SMT201900163T1 (enExample) |
| TR (1) | TR201903312T4 (enExample) |
| WO (1) | WO2015023504A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11201600484TA (en) | 2013-08-12 | 2016-02-26 | Medimmune Llc | Methods for improving asthma symptoms using benralizumab |
| DK3033104T3 (da) * | 2013-08-12 | 2019-06-17 | Astrazeneca Ab | Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab |
| EP3485902A1 (en) * | 2013-10-15 | 2019-05-22 | Astrazeneca AB | Methods for treating chronic obstructive pulmonary disease using benralizumab |
| CA2926089C (en) * | 2013-10-24 | 2022-08-30 | Medimmune, Llc | Stable, aqueous antibody formulations |
| EP3092253B1 (en) | 2014-01-10 | 2021-03-17 | AnaptysBio, Inc. | Antibodies directed against interleukin-33 (il-33) |
| US10699274B2 (en) | 2015-08-24 | 2020-06-30 | Samsung Electronics Co., Ltd. | Apparatus and method for secure electronic payment |
| US10846696B2 (en) | 2015-08-24 | 2020-11-24 | Samsung Electronics Co., Ltd. | Apparatus and method for trusted execution environment based secure payment transactions |
| HK1255922A1 (zh) | 2015-11-04 | 2019-09-06 | Astrazeneca Ab | 二肽基肽酶-4和骨膜素作为嗜酸性粒细胞疾病中嗜酸性粒细胞靶向治疗药物临床反应的预测因子 |
| JP7174492B2 (ja) * | 2017-01-04 | 2022-11-17 | ウォルグ ファーマシューティカルズ （ハンジョウ） カンパニー，リミテッド | Ｓ－アレスチンペプチドおよびその治療的使用 |
| RU2698048C2 (ru) * | 2017-10-03 | 2019-08-21 | Закрытое Акционерное Общество "Биокад" | МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα |
| TW202021983A (zh) * | 2018-09-21 | 2020-06-16 | 美商安納普提斯生物公司 | 用於嗜伊紅性氣喘之抗il-33療法 |
| TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1241944C (zh) | 1995-09-11 | 2006-02-15 | 协和发酵工业株式会社 | 抗人白介素－5受体α链的抗体 |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| AU3672800A (en) | 1999-04-09 | 2000-11-14 | Kyowa Hakko Kogyo Co. Ltd. | Method for controlling the activity of immunologically functional molecule |
| WO2001060405A1 (en) | 2000-02-15 | 2001-08-23 | Kyowa Hakko Kogyo Co., Ltd. | Eosinophil-specific apoptosis inducer |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US8093357B2 (en) | 2002-03-01 | 2012-01-10 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| EP1688437A4 (en) | 2003-10-08 | 2007-09-26 | Kyowa Hakko Kogyo Kk | ANTIBODY COMPOSITION SPECIFICALLY BINDING TO IL-5 RECEPTOR |
| US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| DK1931709T3 (en) | 2005-10-03 | 2017-03-13 | Xencor Inc | FC VARIETIES WITH OPTIMIZED FC RECEPTOR BINDING PROPERTIES |
| ES2558689T3 (es) * | 2007-05-14 | 2016-02-08 | Medimmune, Llc | Métodos para reducir los niveles de eosinófilos |
| RU2383345C1 (ru) * | 2008-08-07 | 2010-03-10 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") | Способ лечения больных бронхиальной астмой |
| AU2010322066A1 (en) * | 2009-11-18 | 2012-06-21 | Medicinova, Inc. | Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom |
| WO2012083132A2 (en) | 2010-12-16 | 2012-06-21 | Genentech, Inc. | Diagnosis and treatments relating to th2 inhibition |
| EP2710370A4 (en) | 2011-05-18 | 2015-01-07 | Medimmune Llc | METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS |
| CA2853858A1 (en) | 2011-11-01 | 2013-05-10 | Medimmune, Llc | Methods for reducing the frequency and severity of acute exacerbations of asthma |
| SG11201600484TA (en) | 2013-08-12 | 2016-02-26 | Medimmune Llc | Methods for improving asthma symptoms using benralizumab |
| DK3033104T3 (da) * | 2013-08-12 | 2019-06-17 | Astrazeneca Ab | Fremgangsmåder til forøgelse af forceret eksspiratorisk volumen hos astmatikere ved anvendelse af benralizumab |
-
2014
- 2014-08-07 CN CN201480043448.XA patent/CN105451760A/zh active Pending
- 2014-08-07 BR BR112016002401A patent/BR112016002401A8/pt not_active Application Discontinuation
- 2014-08-07 HR HRP20190405TT patent/HRP20190405T1/hr unknown
- 2014-08-07 LT LTEP14835826.0T patent/LT3033101T/lt unknown
- 2014-08-07 PL PL14835826T patent/PL3033101T3/pl unknown
- 2014-08-07 HK HK16109784.3A patent/HK1221644A1/zh unknown
- 2014-08-07 ME MEP-2019-75A patent/ME03348B/me unknown
- 2014-08-07 SG SG10202005560UA patent/SG10202005560UA/en unknown
- 2014-08-07 WO PCT/US2014/050080 patent/WO2015023504A1/en not_active Ceased
- 2014-08-07 HU HUE14835826A patent/HUE042607T2/hu unknown
- 2014-08-07 SG SG11201600481UA patent/SG11201600481UA/en unknown
- 2014-08-07 KR KR1020227013308A patent/KR20220057637A/ko not_active Ceased
- 2014-08-07 TR TR2019/03312T patent/TR201903312T4/tr unknown
- 2014-08-07 JP JP2016534614A patent/JP6746495B2/ja active Active
- 2014-08-07 US US14/453,942 patent/US9441037B2/en active Active
- 2014-08-07 PT PT14835826T patent/PT3033101T/pt unknown
- 2014-08-07 CN CN202010449434.5A patent/CN111588848A/zh active Pending
- 2014-08-07 EP EP14835826.0A patent/EP3033101B1/en active Active
- 2014-08-07 ES ES14835826T patent/ES2716906T3/es active Active
- 2014-08-07 SM SM20190163T patent/SMT201900163T1/it unknown
- 2014-08-07 MX MX2016001383A patent/MX368508B/es active IP Right Grant
- 2014-08-07 DK DK14835826.0T patent/DK3033101T3/en active
- 2014-08-07 KR KR1020167006559A patent/KR102390714B1/ko active Active
- 2014-08-07 SI SI201431109T patent/SI3033101T1/sl unknown
- 2014-08-07 RU RU2016108723A patent/RU2676333C2/ru active
- 2014-08-07 AU AU2014306956A patent/AU2014306956B2/en active Active
- 2014-08-07 RS RS20190305A patent/RS58404B1/sr unknown
- 2014-08-07 CA CA2918105A patent/CA2918105C/en active Active
-
2016
- 2016-09-02 US US15/255,508 patent/US20170198049A1/en not_active Abandoned
-
2019
- 2019-03-12 CY CY20191100294T patent/CY1122132T1/el unknown
-
2020
- 2020-02-24 AU AU2020201327A patent/AU2020201327A1/en not_active Abandoned
- 2020-04-03 JP JP2020067797A patent/JP2020128375A/ja not_active Withdrawn
-
2022
- 2022-06-07 JP JP2022092216A patent/JP2022120009A/ja active Pending
-
2024
- 2024-07-05 JP JP2024108991A patent/JP2024129139A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL291446A (en) | Anti-trop2 antibodies and methods for producing same | |
| HUE042607T2 (hu) | Eljárások asztma exacerbációs gyakoriságának csökkentésére benralizumab alkalmazásával | |
| IL246002A0 (en) | Novel methods | |
| PL3305778T3 (pl) | Inhibitory kalikreiny osoczowej | |
| HUE14755117T2 (hu) | Plazma-kallikrein inhibitorok | |
| HUE057530T2 (hu) | Integrált eljárás szénhidrogének elõállítására | |
| HUE045051T2 (hu) | Eljárás propilén-oxid elõállítására | |
| LT3563837T (lt) | Terapija bakteriofagu | |
| HUE053751T2 (hu) | Eljárás iopamidol elõállítására | |
| GB201313771D0 (en) | Acoustic liner | |
| ZA201507475B (en) | Method for the treatment of gas | |
| SG10201708272SA (en) | Method of Viral Inhibition | |
| EP2875389A4 (en) | ACOUSTIC ISOLATOR FOR DRILLING TOOLS | |
| EP2963676A4 (en) | susceptor | |
| IL244487A0 (en) | A method for the synthesis of irinotecan | |
| PT2799426T (pt) | Novo processo para a síntese de aminaftona | |
| PL2883461T3 (pl) | Sposób wytwarzania aktywnej folistatyny | |
| EP2943578A4 (en) | Dnazyme for silencing the expression of egfr | |
| GB201301125D0 (en) | Methods for improving the efficency of gene targeting | |
| SG11201602693QA (en) | Methods and intermediates for preparing macrolactams | |
| EP3025467A4 (en) | DETERMINATION OF A SEQUENCE OF PILOT FREQUENCIES | |
| DK3063370T3 (da) | Frakturkaraterisering | |
| PL3063156T3 (pl) | Sposób oczyszczania lecytyny | |
| GB201303254D0 (en) | Cross braced tympanic guitar | |
| IL244646A0 (en) | Process for preparing 5-fluoro-1-alkyl-3-fluoroalkyl-1h-pyrazole-4-carbaldehyde |